Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Rogaratinib
×
1 year
×
Clear all
Filters
3
NCT03473756
2025-04-09
FORT-2
Bayer
Phase 1
Completed
37 enrolled
15 charts